$6.6M for Cardiorobotics
Cardiorobotics, a developer of a robotic catheter for heart procedures, has raised $6.6 million of a planned $12.5 million round of equity and rights financing, according to an SEC filing. The firm lists a Raynham, MA, address. Xconomy wrote about the firm’s “snake” robotics platform in 2009, after the company took in $11.6 million in Series A financing to develop its technology for procedures to fix irregular heart beats or a condition called atrial fibrillation. The firm’s previous investors include Eagle Ventures, Pittsburgh Life Sciences Greenhouse, and Slater Technology Fund.